NCT00100737 2006-02-06Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)Chiron CorporationPhase 2 Terminated300 enrolled